Literature DB >> 24037761

Interaction of Yersinia enterocolitica biovar 1A with cultured cells in vitro does not reflect the two previously identified clonal groups.

Mahesh S Dhar1, Jugsharan S Virdi1.   

Abstract

Yersinia enterocolitica biovar 1A strains have been delineated into two clonal groups (A and B) based on repetitive extragenic palindrome- and enterobacterial repetitive intergenic consensus-PCR genotyping. The present study investigated the interaction of Y. enterocolitica biovar 1A strains with cultured cells in vitro by their ability to adhere, invade and survive within these cells. The response of macrophages to these strains was also studied by quantifying the expression of inducible nitric oxide synthase, production of nitric oxide and cytokines, and activation of NFκB. The survival rate of clonal group B strains inside macrophages was significantly higher than that of clonal group A strains. In addition, strains harbouring the fepA gene showed better survival inside macrophages. However, the production of nitric oxide and cytokines and activation of NFκB did not show any significant differences between the two clonal groups. In this study, interaction of Y. enterocolitica biovar 1A with cultured cells in vitro did not reflect the previously identified clonal groups, but was more dependent on the characteristics of the individual strains. Therefore, a combination of genotype and phenotype data must be used to characterize this extremely heterogeneous organism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037761     DOI: 10.1099/jmm.0.056077-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  1 in total

1.  Proteomic analysis reveals the damaging role of low redox laccase from Yersinia enterocolitica strain 8081 in the midgut of Helicoverpa armigera.

Authors:  Shruti Ahlawat; Deepti Singh; Asha Yadav; Amarjeet Kumar Singh; Jugsharan Singh Virdi; Krishna Kant Sharma
Journal:  Biotechnol Lett       Date:  2020-05-29       Impact factor: 2.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.